NCT01280201 2019-05-29Pazopanib as Single Agent in Advanced NETsGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed44 enrolled 17 charts
NCT01099540 2015-12-29Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine TumorSamsung Medical CenterPhase 2 Completed37 enrolled